Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Clinical trial NCT04068194 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04068194
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Malignant Solid Neoplasm Locally Advanced Unresectable Cholangiocarcinoma Locally Advanced Unresectable Gallbladder Carcinoma Locally Advanced Unresectable Malignant Solid Neoplasm Metastatic Cholangiocarcinoma Metastatic Gallbladder Carcinoma Metastatic Malignant Solid Neoplasm Stage III Gallbladder Cancer AJCC v8 Stage IV Gallbladder Cancer AJCC v8 Unresectable Malignant Solid Neoplasm

Start date: 2020-04-07
Primary completion: 2027-07-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.